ZNO Zoono Group Limited

—Mkt Cap: —P/E: —

Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, an…

Key Statistics

Company
Market Cap—
Enterprise Value13.26M USD
Revenue (TTM)1.19M USD
Gross Profit173.51K USD
Net Income (TTM)-5.75M USD
Revenue/Share0.0040 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorConsumer Defensive
IndustryHousehold & Personal Products
ISINAU000000ZNO4
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG1.78
EV/EBITDA-13.97
EV/Revenue11.13
P/S8.95
P/B5.25
EPS (TTM)0.00
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin26.15%
Oper. Margin-31.79%
EBITDA Margin-79.69%
Profit Margin-866.12%
ROE-133.19%
ROA-92.36%
Growth
Revenue Growth125.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.06M USD
CapEx (TTM)—
FCF Margin-50.63%
FCF Yield—
Net Debt65.98K USD
Net Debt/EBITDA-0.07
Balance Sheet
Debt/Equity0.12
Current Ratio4.78
Quick Ratio0.37
Book Value/Sh0.0072 AUD
Cash/Share0.0010 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 4, 2020
Pay Date—
Splits
Last Split1:2
Split DateJan 20, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.406.21M
Float177.65M
Insiders58.29%
Institutions0.49%
Technical
SMA 500.0501 AUD
SMA 2000.0600 AUD
Beta1.14
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)38.29K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—